10x Genomics Launches Xenium Prime 5K Pan-Tissue Spatial Transcriptomics Assay
August 5, 2026 • Source: GEN
10x Genomics expanded its spatial biology portfolio with Xenium Prime 5K, enabling subcellular in situ profiling of 5,000 genes across FFPE and fresh-frozen human and mouse tissues.
**Executive Summary (2026-08-05):** 10x Genomics expanded its spatial biology portfolio with Xenium Prime 5K, enabling subcellular in situ profiling of 5,000 genes across FFPE and fresh-frozen human and mouse tissues. Source: GEN.
Technical Architecture & R&D Impact
Paired with automated multimodal cell segmentation and Cloud Analysis pipelines, Xenium Prime 5K increases transcript capture sensitivity while preserving tissue morphology for same-section H&E and immunofluorescence protein co-detection in oncology translational research.
Enterprise Biopharma Procurement Takeaways
For computational biology leads, medicinal chemists, and R&D IT architects, this milestone underscores the rapid convergence of wet-lab experimental validation and scalable cloud foundation models during H2 2026. Teams evaluating vendors in the Launch category should benchmark API reproducibility, GxP audit readiness, and zero-data-retention VPC deployment terms.
Related Products
Published August 5, 2026
More NewsLast updated: August 5, 2026
